These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 19962938
21. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy. Arnulf I, Mignot E. Sleep; 2004 Nov 01; 27(7):1242-3. PubMed ID: 15586777 [No Abstract] [Full Text] [Related]
22. Catathrenia under sodium oxybate in narcolepsy with cataplexy. Poli F, Ricotta L, Vandi S, Franceschini C, Pizza F, Palaia V, Moghadam KK, Banal D, Vetrugno R, Thorpy MJ, Plazzi G. Sleep Breath; 2012 Jun 01; 16(2):427-34. PubMed ID: 21484510 [Abstract] [Full Text] [Related]
23. Gamma hydroxybutyrate (Xyrem) for narcolepsy. Med Lett Drugs Ther; 2002 Dec 09; 44(1145):103-5. PubMed ID: 12473959 [No Abstract] [Full Text] [Related]
24. Sodium oxybate-induced sleep driving and sleep-related eating disorder. Wallace DM, Maze T, Shafazand S. J Clin Sleep Med; 2011 Jun 15; 7(3):310-1. PubMed ID: 21677903 [Abstract] [Full Text] [Related]
25. Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy. Owen RT. Drugs Today (Barc); 2008 Mar 15; 44(3):197-204. PubMed ID: 18536781 [Abstract] [Full Text] [Related]
26. Problems with latest Xyrem group investigation. Hudgel DW. J Clin Sleep Med; 2006 Jan 15; 2(1):96; author reply 97. PubMed ID: 17557445 [No Abstract] [Full Text] [Related]
32. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Mansukhani MP, Kotagal S. Sleep Med; 2012 Jun 15; 13(6):606-10. PubMed ID: 22445591 [Abstract] [Full Text] [Related]
33. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Weaver TE, Cuellar N. Sleep; 2006 Sep 15; 29(9):1189-94. PubMed ID: 17040006 [Abstract] [Full Text] [Related]
34. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D. Arch Neurol; 2008 Oct 15; 65(10):1337-40. PubMed ID: 18852348 [Abstract] [Full Text] [Related]
35. Psychosis in a 22-Year-Old Woman With Narcolepsy After Restarting Sodium Oxybate. Buckley PJ, Wolf CT. Psychosomatics; 2018 Oct 15; 59(3):298-301. PubMed ID: 29108652 [No Abstract] [Full Text] [Related]
36. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep; 2003 Feb 01; 26(1):31-5. PubMed ID: 12627729 [Abstract] [Full Text] [Related]
37. Prescribing sodium oxybate for narcolepsy: end the postcode lottery and apply some common sense. Watts JS. BMJ; 2016 May 24; 353():i2881. PubMed ID: 27220346 [No Abstract] [Full Text] [Related]
38. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy. Black J, Pardi D, Hornfeldt CS, Inhaber N. J Clin Sleep Med; 2010 Dec 15; 6(6):596-602. PubMed ID: 21206549 [Abstract] [Full Text] [Related]
39. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Murali H, Kotagal S. Sleep; 2006 Aug 15; 29(8):1025-9. PubMed ID: 16944670 [Abstract] [Full Text] [Related]
40. Response to Editorial: "Xyrem safety: The debate continues". Zvosec DL, Smith SW. Sleep Med; 2010 Jan 15; 11(1):108; author reply 108-9. PubMed ID: 19959395 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]